Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-“Chemobrain”
Amelia Maria Găman, Adriana Uzoni, Aurel Popa‐Wagner, et al.
Aging and Disease (2016) Vol. 7, Iss. 3, pp. 307-307
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Mechanisms of Chemotherapy-Induced Neurotoxicity
Halina Waś, Agata Borkowska, Ana Bagüés, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 129
Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors
Xiaojia Ren, Diana Boriero, Luksana Chaiswing, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 6, pp. 1088-1097
Open Access | Times Cited: 99
Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus
Ciara Bagnall-Moreau, Sovira Chaudhry, Kaliris Y. Salas-Ramirez, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 7159-7172
Open Access | Times Cited: 92
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?
Sanne B. Schagen, Andrey S. Tsvetkov, Annette Compter, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 3, pp. 173-185
Closed Access | Times Cited: 65
Senolytic treatment alleviates doxorubicin‐induced chemobrain
Vivekananda Budamagunta, Ashok Kumar, Asha Rani, et al.
Aging Cell (2024) Vol. 23, Iss. 2
Open Access | Times Cited: 9
Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity
Jacopo Junio Valerio Branca, Mario Maresca, Gabriele Morucci, et al.
Oncotarget (2018) Vol. 9, Iss. 34, pp. 23426-23438
Open Access | Times Cited: 73
Doxorubicin chemotherapy-induced “chemo-brain”: Meta-analysis
Sarah Eide, Zhong‐Ping Feng
European Journal of Pharmacology (2020) Vol. 881, pp. 173078-173078
Closed Access | Times Cited: 66
Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review
Longqin Lv, Shanping Mao, Huimin Dong, et al.
Journal of Oncology (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 54
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus
Theresa Currier Thomas, Joshua A. Beitchman, François Pomerleau, et al.
Brain Research (2017) Vol. 1672, pp. 10-17
Open Access | Times Cited: 50
Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration
C.V. Cardoso, Marcelo P. Barros, André Luís Lacerda Bachi, et al.
Behavioural Brain Research (2019) Vol. 378, pp. 112233-112233
Closed Access | Times Cited: 44
Animal models of chemotherapy-induced cognitive decline in preclinical drug development
Jeena John, Manas Kinra, Jayesh Mudgal, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3025-3053
Open Access | Times Cited: 37
Calorie restriction conferred improvement effect on long-term rehabilitation of ischemic stroke via gut microbiota
Jiating Huang, Yuqin Mao, Bing Han, et al.
Pharmacological Research (2021) Vol. 170, pp. 105726-105726
Closed Access | Times Cited: 36
Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy
Ahram Jang, Boryana Petrova, Taek-Chin Cheong, et al.
Neuron (2022) Vol. 110, Iss. 20, pp. 3288-3301.e8
Open Access | Times Cited: 26
Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
Fabio Ntagwabira, Madison Trujillo, Taylor McElroy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2008-2008
Open Access | Times Cited: 23
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
Phytochemical profiling and neuroprotective activity of Callistemon subulatus leaves against cyclophosphamide-induced chemobrain
Omyma Rabie, Heba A. S. El‐Nashar, Mina Y. George, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115596-115596
Open Access | Times Cited: 14
Doxorubicin treatment has a biphasic effect over time on dopamine release and impulsive behavior in Wistar rats
Kiersten Jade Garcia, Jacob T. Theismann, Tadd D. Schneider, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Neuroprotective Action of Coumarin Derivatives through Activation of TRKB-CREB-BDNF Pathway and Reduction of Caspase Activity in Neuronal Cells Expressing Pro-Aggregated Tau Protein
Te‐Hsien Lin, Kuo‐Hsuan Chang, Ya‐Jen Chiu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12734-12734
Open Access | Times Cited: 20
Alpha-Lipoic Acid Ameliorates Doxorubicin-Induced Cognitive Impairments by Modulating Neuroinflammation and Oxidative Stress via NRF-2/HO-1 Signaling Pathway in the Rat Hippocampus
Roshan Lal, Ravinder Naik Dharavath, Kanwaljit Chopra
Neurochemical Research (2023) Vol. 48, Iss. 8, pp. 2476-2489
Closed Access | Times Cited: 11
Diminished stress resistance and defective adaptive homeostasis in age-related diseases
Naomi Lomeli, Daniela A. Bota, Kelvin J.A. Davies
Clinical Science (2017) Vol. 131, Iss. 21, pp. 2573-2599
Open Access | Times Cited: 33
Chemobrain as a Product of Growing Success in Chemotherapy - Focus On Glia As Both A Victim And A Cure
Piotr Walczak, Mirosław Janowski
Neuropsychiatry (2019) Vol. 09, Iss. 01
Open Access | Times Cited: 30
Effect of Metformin on Doxorubicin-Induced Memory Dysfunction
Ibrahim Alharbi, Hindi S. Alharbi, Yasser Almogbel, et al.
Brain Sciences (2020) Vol. 10, Iss. 3, pp. 152-152
Open Access | Times Cited: 30
Nrf2 Signaling Pathway: a Potential Therapeutic Target in Combating Oxidative Stress and Neurotoxicity in Chemotherapy-Induced Cognitive Impairment
Roshan Lal, Ravinder Naik Dharavath, Kanwaljit Chopra
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 593-608
Closed Access | Times Cited: 9
Chemotherapy-induced cognitive impairment and glia: A new take on chemobrain?
Maria Barbosa-Azevedo, Ana Dias-Carvalho, Félix Carvalho, et al.
Toxicology and Applied Pharmacology (2024) Vol. 492, pp. 117085-117085
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top